Total planned funding: $1,308,267,155
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $267,158,959 |
Zambia | $208,336,118 |
Tanzania | $173,063,127 |
Mozambique | $132,859,439 |
Uganda | $110,394,760 |
Kenya | $97,264,930 |
Zimbabwe | $53,566,253 |
Haiti | $47,944,197 |
Rwanda | $43,899,032 |
Democratic Republic of the Congo | $43,359,367 |
Ethiopia | $19,704,263 |
South Africa | $16,642,059 |
Cameroon | $14,714,148 |
Côte d'Ivoire | $12,119,352 |
Malawi | $11,409,150 |
Eswatini | $7,635,838 |
Western Hemisphere Region | $7,512,526 |
Lesotho | $6,742,370 |
Namibia | $6,152,831 |
Burundi | $6,108,947 |
West Africa Region | $5,461,164 |
Asia Regional Program | $4,135,000 |
Ukraine | $3,852,913 |
Vietnam | $2,440,111 |
Angola | $2,120,256 |
Botswana | $1,854,918 |
Ghana | $1,010,959 |
South Sudan | $445,752 |
enumerations.Philippines | $358,416 |
Organizational Types
Private Contractor | $1,308,267,155 |
Program Areas
Treatment | $1,089,072,789 |
Care | $88,575,759 |
Prevention | $58,781,075 |
Governance and Systems | $56,407,161 |
Testing | $14,419,412 |
Budget Codes
HTXD: Treatment: ARV Drugs | $793,339,723 |
HTXS: Treatment: Adult Treatment | $270,838,176 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $48,015,709 |
OHSS: Health Systems Strengthening | $42,941,281 |
HBHC: Care: Adult Care and Support | $36,041,220 |
HVTB: Care: TB/HIV | $28,773,154 |
PDTX: Treatment: Pediatric Treatment | $24,894,890 |
PDCS: Care: Pediatric Care and Support | $21,563,084 |
HVCT: Testing: HIV Testing and Counseling | $14,419,412 |
HLAB: Laboratory Infrastructure | $10,251,306 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,254,970 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,681,867 |
HVSI: Strategic Information | $3,214,574 |
HKID: Care: Orphans and Vulnerable Children | $2,198,301 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $661,764 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $166,765 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Chemonics International:
$1,308,267,155
View countries